Clostridium difficile and inflammatory bowel disease.

Clostridium difficile colitis has doubled in North America over the past 5 years and recent reports have demonstrated an increase in incidence and severity of these infections in patients with inflammatory bowel disease (IBD; Crohn's disease, ulcerative colitis). Studies from single institutions as well as trends identified in nationwide inpatient databases have shown that IBD patients with concomitant C. difficile infection experience increased morbidity and mortality. Results from our center have shown that over half of C. difficile-infected IBD patients will require hospitalization and the colectomy rate may approach 20%. Because C. difficile colitis will both mimic and precipitate an IBD flare, it is essential that clinicians be vigilant to identify and address this infectious complication, as empiric treatment with corticosteroids without appropriate antibiotics may precipitate deterioration. The majority of IBD patients appear to contract C. difficile as outpatients, and a prior history of colitis appears to be the most significant risk factor for acquiring this infection. In addition to C. difficile colitis, IBD patients are now known to be at risk for C. difficile enteritis as well as infections in reconstructed ileoanal pouches. An additional challenge facing C. difficile infections in IBD patients is the decreased efficacy of metronidazole, and the need for oral vancomycin in patients requiring hospitalization. In this review we summarize the present knowledge regarding C. difficile infection in the setting of IBD, including unique clinical scenarios facing IBD patients, diagnostic algorithms, and treatment approaches.

[1]  M. Abreu,et al.  Clinical Outcomes of Patients with Ulcerative Colitis and Co-existing Clostridium difficile Infection , 2010, Digestive Diseases and Sciences.

[2]  A. Staiano,et al.  Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. , 2009, The Journal of pediatrics.

[3]  Dawn B. Beaulieu,et al.  S1145 Long-Term Impact of Clostridium difficile On Inflammatory Bowel Disease , 2009 .

[4]  D. Leffler,et al.  Treatment of Clostridium difficile-associated disease. , 2009, Gastroenterology.

[5]  R. Chinn,et al.  National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. , 2009, American journal of infection control.

[6]  R. P. Ross,et al.  The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission , 2009, The American Journal of Gastroenterology.

[7]  C. Kelly A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. , 2009, JAMA.

[8]  K. Garey,et al.  WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texas. , 2009, Anaerobe.

[9]  P. Rutgeerts,et al.  Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. , 2009, Journal of Crohn's & colitis.

[10]  K. Garey,et al.  Rifaximin in Treatment of Recurrent Clostridium difficile-associated Diarrhea: An Uncontrolled Pilot Study , 2009, Journal of clinical gastroenterology.

[11]  E. Dubberke,et al.  Review of Current Literature on the Economic Burden of Clostridium difficile Infection , 2009, Infection Control & Hospital Epidemiology.

[12]  L. Mcfarland Renewed interest in a difficult disease: Clostridium difficile infections – epidemiology and current treatment strategies , 2009, Current opinion in gastroenterology.

[13]  K. Garey,et al.  Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. , 2008, The Journal of hospital infection.

[14]  E. Giovannucci,et al.  Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial , 2008, JAMA.

[15]  H. Dupont,et al.  Clostridium difficile infection in patients with ileal pouch-anal anastomosis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  K. Aktories,et al.  Processing of Clostridium difficile toxins. , 2008, Journal of medical microbiology.

[17]  G. Kaplan,et al.  A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.

[18]  R. Nelson,et al.  Probiotics for treatment of Clostridium difficile-associated colitis in adults. , 2008, The Cochrane database of systematic reviews.

[19]  J. Bartlett,et al.  Clinical recognition and diagnosis of Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Carlene A. Muto,et al.  Treatment of Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Carlene A. Muto,et al.  Measures to control and prevent Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Oldfield Ec rd Use of a rifaximin "chaser" in the treatment of recurrent Clostridium difficile-associated diarrhea. , 2008 .

[23]  K. Aktories,et al.  Clostridium difficile Glucosyltransferase Toxin B-essential Amino Acids for Substrate Binding* , 2007, Journal of Biological Chemistry.

[24]  A. Ananthakrishnan,et al.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.

[25]  Melinda B Davis,et al.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  D. Musher,et al.  Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. , 2007, The Journal of antimicrobial chemotherapy.

[27]  D. Gerding,et al.  Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Kimberly A. Reske,et al.  Incidence of Clostridium difficile infection in inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  S. Fanning,et al.  Isolation and Characterization of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland , 2017 .

[30]  Dawn B. Beaulieu,et al.  Impact of Clostridium difficile on inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[31]  J. Weese,et al.  Clostridium difficile in Retail Ground Meat, Canada , 2007, Emerging infectious diseases.

[32]  C. Brensinger,et al.  A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis. , 2007, Gastroenterology.

[33]  D. Binion,et al.  Clostridium difficile Enteritis: An Early Postoperative Complication in Inflammatory Bowel Disease Patients After Colectomy , 2007, Journal of Gastrointestinal Surgery.

[34]  D. Juurlink,et al.  Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  J. Goldblum,et al.  Clostridium Difficile-Associated Pouchitis , 2006, Digestive Diseases and Sciences.

[36]  S. Suissa,et al.  Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy , 2006, Canadian Medical Association Journal.

[37]  Dawn B. Beaulieu,et al.  Rifaximin and Treatment of Recurrent Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: 1206 , 2006 .

[38]  D. Musher,et al.  Nitazoxanide for the treatment of Clostridium difficile colitis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  J. Bartlett New drugs for Clostridium difficile infection. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  D. Rampton,et al.  “Diversion” Colitis Caused by Clostridium difficile Infection: Report of a Case , 2006, Diseases of the colon and rectum.

[41]  D. Gerding,et al.  Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. , 2006, The Journal of infectious diseases.

[42]  D. Musher Pneumococcal vaccine--direct and indirect ("herd") effects. , 2006, The New England journal of medicine.

[43]  L. Mcfarland Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease , 2006, The American Journal of Gastroenterology.

[44]  K. Iwata,et al.  Epidemic Clostridium difficile. , 2006, The New England journal of medicine.

[45]  C. Rees,et al.  Intravenous Immunoglobulin for the Treatment of Severe, Refractory, and Recurrent Clostridium difficile Diarrhea , 2006, Diseases of the colon and rectum.

[46]  S. Routhier,et al.  Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  M. Owings,et al.  Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–2003 , 2006, Emerging Infectious Diseases.

[48]  K. Carroll,et al.  Effective Detection of Toxigenic Clostridium difficile by a Two-Step Algorithm Including Tests for Antigen and Cytotoxin , 2006, Journal of Clinical Microbiology.

[49]  T. Åkerlund,et al.  Correlation of Disease Severity with Fecal Toxin Levels in Patients with Clostridium difficile-Associated Diarrhea and Distribution of PCR Ribotypes and Toxin Yields In Vitro of Corresponding Isolates , 2006, Journal of Clinical Microbiology.

[50]  S. Clark,et al.  The outcome of surgery in fulminant Clostridium difficile colitis , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[51]  C. Cunningham-Rundles,et al.  Inflammatory and autoimmune complications of common variable immune deficiency. , 2006, Autoimmunity reviews.

[52]  J. Songer,et al.  Clostridium difficile: an important pathogen of food animals. , 2006, Anaerobe.

[53]  E. Kuijper,et al.  Emergence of Clostridium difficile-associated disease in North America and Europe. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[54]  F. Hayetian,et al.  Ileal perforation secondary to Clostridium difficile enteritis: report of 2 cases. , 2006, Archives of surgery.

[55]  A. Barkun,et al.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. , 2005, JAMA.

[56]  Stuart Johnson,et al.  An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.

[57]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[58]  L. Lanthier,et al.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  L. Valiquette,et al.  Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec , 2005, Canadian Medical Association Journal.

[60]  Jon Brazier,et al.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.

[61]  D. Musher,et al.  Treatment of Clostridium difficile-associated disease: old therapies and new strategies. , 2005, The Lancet. Infectious diseases.

[62]  J. Starr Clostridium difficile associated diarrhoea: diagnosis and treatment , 2005, BMJ : British Medical Journal.

[63]  D. Musher,et al.  Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  K. Carroll,et al.  Frequency of Sample Submission for Optimal Utilization of the Cell Culture Cytotoxicity Assay for Detection of Clostridium difficile Toxin , 2005, Journal of Clinical Microbiology.

[65]  J. Pépin,et al.  Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[66]  J. Ballard,et al.  Clostridium difficile Toxins: Mechanism of Action and Role in Disease , 2005, Clinical Microbiology Reviews.

[67]  Carlene A. Muto,et al.  A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use , 2005, Infection Control & Hospital Epidemiology.

[68]  M. Parmar Treating C. difficile , 2005, Canadian Medical Association Journal.

[69]  C. Branger,et al.  Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. , 2005, Journal of medical microbiology.

[70]  L. Mcfarland Alternative treatments for Clostridium difficile disease: what really works? , 2005, Journal of medical microbiology.

[71]  D. Gerding,et al.  A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[72]  P. A. Kantrowitz,et al.  Clostridium difficile enteritis , 1993, Digestive Diseases and Sciences.

[73]  J. Leighton,et al.  The Diagnostic Yield of Stool Pathogen Studies During Relapses of Inflammatory Bowel Disease , 2004, Journal of clinical gastroenterology.

[74]  Louis Valiquette,et al.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.

[75]  D. Rampton,et al.  Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool , 2004, European journal of gastroenterology & hepatology.

[76]  A. Huang,et al.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies , 2004, Canadian Medical Association Journal.

[77]  S. Poutanen,et al.  Clostridium difficile-associated diarrhea in adults , 2004, Canadian Medical Association Journal.

[78]  I. Odenholt,et al.  A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea. , 2004, The Journal of antimicrobial chemotherapy.

[79]  M. Wilcox Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea. , 2004, The Journal of antimicrobial chemotherapy.

[80]  R. Gaynes,et al.  Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  P. Giannasca,et al.  Active and passive immunization against Clostridium difficile diarrhea and colitis. , 2004, Vaccine.

[82]  E. Elinav,et al.  Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis , 2004, International Journal of Colorectal Disease.

[83]  M. Rupnik,et al.  Binary toxin producing Clostridium difficile strains. , 2003, Anaerobe.

[84]  J. Starr,et al.  Clostridium difficile in a geriatric unit: a prospective epidemiological study employing a novel S-layer typing method. , 2003, Journal of medical microbiology.

[85]  M. Wilcox,et al.  Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. , 2003, The Journal of hospital infection.

[86]  J. Bakken,et al.  Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[87]  A. Thillainayagam,et al.  Clostridium Difficile Infection—An Unusual Cause of Refractory Pouchitis: Report of a Case , 2003, Diseases of the colon and rectum.

[88]  C. Kelly,et al.  Underlying Disease Severity as a Major Risk Factor for Nosocomial Clostridium difficile Diarrhea , 2002, Infection Control & Hospital Epidemiology.

[89]  I. Fong,et al.  Fulminant clostridium difficile colitis without diarrhea: lack of emphasis in diagnostic guidelines , 2002, American Journal of Gastroenterology.

[90]  Lynne V McFarland,et al.  Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease , 2002, American Journal of Gastroenterology.

[91]  C. Sirio,et al.  Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications , 2002, Annals of surgery.

[92]  C. Kelly,et al.  Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  J. Bartlett,et al.  Clinical practice. Antibiotic-associated diarrhea. , 2002, New England Journal of Medicine.

[94]  S. Durning,et al.  Clostridium difficile small bowel enteritis occurring after total colectomy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[95]  L. Peterson,et al.  Fatal Pseudomembranous Colitis Associated with a Variant Clostridium difficile Strain Not Detected by Toxin A Immunoassay , 2001, Annals of Internal Medicine.

[96]  J. Tjandra,et al.  Fatal Clostridium difficile infection of the small bowel after complex colorectal surgery , 2001, ANZ journal of surgery.

[97]  J. Gradon,et al.  Extracolonic Manifestations of Clostridium difficile Infections: Presentation of 2 Cases and Review of the Literature , 2001, Medicine.

[98]  E. Mylonakis,et al.  Clostridium difficile--Associated diarrhea: A review. , 2001, Archives of internal medicine.

[99]  L B Reller,et al.  Practice guidelines for the management of infectious diarrhea. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[100]  C. Kelly,et al.  Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea , 2001, The Lancet.

[101]  M. Wilcox,et al.  Hospital disinfectants and spore formation by Clostridium difficile , 2000, The Lancet.

[102]  T. Leet,et al.  Environmental control to reduce transmission of Clostridium difficile. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[103]  M. Schein,et al.  Acute Abdomen and Clostridium difficile Colitis: Still a Lethal Combination , 2000, Digestive Surgery.

[104]  Z. Vesoulis,et al.  Pseudomembranous enteritis after proctocolectomy , 2000, Diseases of the colon and rectum.

[105]  C. Kelly,et al.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. , 2000, The New England journal of medicine.

[106]  H. Solomon,et al.  Clostridium difficile colitis requiring subtotal colectomy in a renal transplant recipient: a case report and review of literature. , 1998, Transplantation proceedings.

[107]  D. Yadav,et al.  Clostridium difficile colitis: factors influencing treatment failure and relapse—a prospective evaluation , 1998, American Journal of Gastroenterology.

[108]  G E Bignardi,et al.  Risk factors for Clostridium difficile infection. , 1998, The Journal of hospital infection.

[109]  M. Alfa,et al.  Survey of Incidence of Clostridium difficile Infection in Canadian Hospitals and Diagnostic Approaches , 1998, Journal of Clinical Microbiology.

[110]  S. Borriello,et al.  Pathogenesis of Clostridium difficile infection. , 1998, The Journal of antimicrobial chemotherapy.

[111]  C. Griffiths,et al.  The role of surgery in pseudomembranous enterocolitis. , 1998, Postgraduate medical journal.

[112]  K. Mealy,et al.  Timing of surgery for fulminating pseudomembranous colitis , 1998, The British journal of surgery.

[113]  R. Fekety Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. , 1997, The American journal of gastroenterology.

[114]  R. Karmy-Jones,et al.  Pseudomembranous colitis with associated fulminant ileitis in the defunctionalized limb of a jejunal-ileal bypass , 1997, Diseases of the colon and rectum.

[115]  M. Weidmann,et al.  Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. , 1997, European journal of biochemistry.

[116]  S. Grundfest-Broniatowski,et al.  Clostridium difficile colitis in the critically Ill , 1996, Diseases of the colon and rectum.

[117]  W. Graninger,et al.  Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[118]  M. Samore,et al.  Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. , 1996, The American journal of medicine.

[119]  H. Yee,et al.  Fatal Clostridium difficile enteritis after total abdominal colectomy. , 1996, Journal of clinical gastroenterology.

[120]  Richard D Moore,et al.  Clostridium difficile Colitis: An Efficient Clinical Approach to Diagnosis , 1995, Annals of Internal Medicine.

[121]  A. Barkun,et al.  Toxic megacolon complicating pseudomembranous enterocolitis , 1995, Diseases of the colon and rectum.

[122]  M. Wilcox,et al.  Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. , 1995, The Journal of antimicrobial chemotherapy.

[123]  L. Peterson,et al.  Clostridium Difficile-Associated Diarrhea and Colitis , 1995, Infection Control & Hospital Epidemiology.

[124]  M. Mulligan,et al.  Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[125]  Elaine Larson,et al.  Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). , 1995, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[126]  L. Morris,et al.  Management of pseudomembranous colitis. , 1994, The American surgeon.

[127]  G. Bongaerts,et al.  Role of toxins A and B in the pathogenesis of Clostridium difficile disease. , 1994, Microbial pathogenesis.

[128]  D. Gerding,et al.  Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. , 1994 .

[129]  M. Holodniy,et al.  Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[130]  K. Lillemoe,et al.  Pseudomembranous colitis: a surgical disease? , 1994, Surgery.

[131]  A. Shah,et al.  Diagnosis and treatment of Clostridium difficile colitis. , 1993, JAMA.

[132]  Fausto,et al.  Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea , 1992, Antimicrobial Agents and Chemotherapy.

[133]  L. Peterson,et al.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. , 1992, The Journal of infectious diseases.

[134]  R. Simmons,et al.  Laparotomy for fulminant pseudomembranous colitis. , 1992, Archives of surgery.

[135]  M. Scheurlen,et al.  Microbic Superinfection in Relapse of Inflammatory Bowel Disease , 1992, Journal of clinical gastroenterology.

[136]  J. Gryboski Clostridium difficile in Inflammatory Bowel Disease Relapse , 1991, Journal of pediatric gastroenterology and nutrition.

[137]  D. Miller,et al.  Perforation complicating rifampin-associated pseudomembranous enteritis. , 1989, Archives of surgery.

[138]  B. Guglielmo,et al.  Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis. , 1989, The Journal of infectious diseases.

[139]  J. Rask-Madsen,et al.  BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS , 1989, The Lancet.

[140]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.

[141]  M. Tvede,et al.  Bacteriotherapy for chronic relapsing Clostridium difficile in six patients , 1989 .

[142]  J. Silva,et al.  Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. , 1989, The American journal of medicine.

[143]  M. Wilson,et al.  Absence of diarrhea in toxic megacolon complicating Clostridium difficile pseudomembranous colitis. , 1988, The American journal of gastroenterology.

[144]  D. Kleinfeld,et al.  Parenteral therapy for antibiotic-associated pseudomembranous colitis. , 1988, The Journal of infectious diseases.

[145]  P. Bingley,et al.  Clostridium difficile colitis following treatment with metronidazole and vancomycin. , 1987, Postgraduate medical journal.

[146]  R. Bolton,et al.  Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. , 1986, Gut.

[147]  M. Dudley,et al.  Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial. , 1986, Archives of internal medicine.

[148]  D. Gordon,et al.  Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. , 1985, Gastroenterology.

[149]  D. Gordon,et al.  Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. , 1985, The American journal of gastroenterology.

[150]  M. Gerson,et al.  Salmonella infections complicating inflammatory bowel disease. , 1985, Journal of clinical gastroenterology.

[151]  K. Saum,et al.  Effects of Clostridium difficile toxins given intragastrically to animals , 1985, Infection and immunity.

[152]  B. Aronsson,et al.  Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. , 1984, Scandinavian journal of infectious diseases.

[153]  D. Gerding,et al.  PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS , 1983, The Lancet.

[154]  J. Shortland,et al.  Pseudomembranous colitis associated with changes in an ileal conduit. , 1983, Journal of clinical pathology.

[155]  D. Rampton,et al.  Nonspecific ulcerative colitis as a sequel to amebic dysentery. , 1983, Journal of clinical gastroenterology.

[156]  R. Möllby,et al.  Occurrence of Clostridium difficile toxin in inflammatory bowel disease. , 1983, Scandinavian journal of gastroenterology.

[157]  K. Das,et al.  Salmonellosis complicating ulcerative colitis. Treatment with trimethoprim-sulfamethoxazole. , 1982, JAMA.

[158]  Tedesco Fj Treatment of recurrent antibiotic-associated pseudomembranous colitis. , 1982 .

[159]  J. Bartlett,et al.  Comparison of two toxins produced by Clostridium difficile , 1981, Infection and immunity.

[160]  B. Greene,et al.  12 MONTH FOLLOW-UP OF MEBENDAZOLE THERAPY FOR ONCHOCERCIASIS , 1981, The Lancet.

[161]  M. Ar,et al.  Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. , 1981 .

[162]  Y. Trnka,et al.  Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. , 1981, Gastroenterology.

[163]  A. Read,et al.  CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHŒA: A ROLE IN INFLAMMATORY BOWEL DISEASE? , 1980, The Lancet.

[164]  Y. Trnka,et al.  THERAPEUTIC IMPLICATIONS OF CLOSTRIDIUM DIFFICILE TOXIN DURING RELAPSE OF CHRONIC INFLAMMATORY BOWEL DISEASE , 1980, The Lancet.

[165]  M. Keighley,et al.  Therapeutic trials of antibiotic associated colitis. , 1980, Scandinavian journal of infectious diseases. Supplementum.

[166]  M. Keighley,et al.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. , 1978, British medical journal.

[167]  J. Bartlett,et al.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. , 1978, The New England journal of medicine.

[168]  J. Bartlett,et al.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. , 1977, The Journal of infectious diseases.

[169]  R. Barton,et al.  Clindamycin-associated colitis. A prospective study. , 1974, Annals of internal medicine.

[170]  J. Crooks,et al.  THE FAMILY DOCTOR IN THE CONTEXT OF BRITAIN'S SOCIAL SERVICES. , 1965, Lancet.

[171]  I. C. Hall,et al.  INTESTINAL FLORA IN NEW-BORN INFANTS: WITH A DESCRIPTION OF A NEW PATHOGENIC ANAEROBE, BACILLUS DIFFICILIS , 1935 .